185 related articles for article (PubMed ID: 15457296)
1. Description of prescribing practices in patients with upper gastrointestinal bleeding receiving intravenous proton pump inhibitors: a multicentre evaluation.
Enns R; Andrews CN; Fishman M; Hahn M; Atkinson K; Kwan P; Levy A
Can J Gastroenterol; 2004 Sep; 18(9):567-71. PubMed ID: 15457296
[TBL] [Abstract][Full Text] [Related]
2. Intravenous proton pump inhibitors before endoscopy in bleeding peptic ulcer with high-risk stigmata: a multicentre comparative study.
Andrews CN; Levy A; Fishman M; Hahn M; Atkinson K; Kwan P; Enns R
Can J Gastroenterol; 2005 Nov; 19(11):667-71. PubMed ID: 16292361
[TBL] [Abstract][Full Text] [Related]
3. Inappropriate use of intravenous pantoprazole: extent of the problem and successful solutions.
Kaplan GG; Bates D; McDonald D; Panaccione R; Romagnuolo J
Clin Gastroenterol Hepatol; 2005 Dec; 3(12):1207-14. PubMed ID: 16361046
[TBL] [Abstract][Full Text] [Related]
4. Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study.
Jensen DM; Pace SC; Soffer E; Comer GM;
Am J Gastroenterol; 2006 Sep; 101(9):1991-9; quiz 2170. PubMed ID: 16968504
[TBL] [Abstract][Full Text] [Related]
5. The novel use of an intravenous proton pump inhibitor in a patient with short bowel syndrome.
Tang SJ; Nieto JM; Jensen DM; Ohning GV; Pisegna JR
J Clin Gastroenterol; 2002 Jan; 34(1):62-3. PubMed ID: 11743248
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitors: a study of GPs' prescribing.
Jones MI; Greenfield SM; Jowett S; Bradley CP; Seal R
Fam Pract; 2001 Jun; 18(3):333-8. PubMed ID: 11356744
[TBL] [Abstract][Full Text] [Related]
7. Prevention of NSAID-associated gastrointestinal lesions: a comparison study pantoprazole versus omeprazole.
Regula J; Butruk E; Dekkers CP; de Boer SY; Raps D; Simon L; Terjung A; Thomas KB; Lühmann R; Fischer R
Am J Gastroenterol; 2006 Aug; 101(8):1747-55. PubMed ID: 16817839
[TBL] [Abstract][Full Text] [Related]
8. Pre-endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non-variceal upper gastrointestinal bleeding.
Keyvani L; Murthy S; Leeson S; Targownik LE
Aliment Pharmacol Ther; 2006 Oct; 24(8):1247-55. PubMed ID: 17014584
[TBL] [Abstract][Full Text] [Related]
9. Treating patients with acute gastrointestinal bleeding or rebleeding.
Pisegna JR
Pharmacotherapy; 2003 Oct; 23(10 Pt 2):81S-86S. PubMed ID: 14587962
[TBL] [Abstract][Full Text] [Related]
10. Potential uses of intravenous proton pump inhibitors to control gastric acid secretion.
Metz DC
Digestion; 2000; 62(2-3):73-81. PubMed ID: 11025353
[TBL] [Abstract][Full Text] [Related]
11. The clinical importance of proton pump inhibitor pharmacokinetics.
Yacyshyn BR; Thomson AB
Digestion; 2002; 66(2):67-78. PubMed ID: 12428065
[TBL] [Abstract][Full Text] [Related]
12. [Proton pump inhibitors in acute ulcer bleeding--what is evident?].
Bohle W; Zoller WG
Dtsch Med Wochenschr; 2000 Dec; 125(51-52):1571-4. PubMed ID: 11199449
[No Abstract] [Full Text] [Related]
13. Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial.
Zargar SA; Javid G; Khan BA; Yattoo GN; Shah AH; Gulzar GM; Sodhi JS; Mujeeb SA; Khan MA; Shah NA; Shafi HM
J Gastroenterol Hepatol; 2006 Apr; 21(4):716-21. PubMed ID: 16677158
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and therapeutic options in the management of nonvariceal upper gastrointestinal bleeding.
Pais SA; Yang R
Curr Gastroenterol Rep; 2003 Dec; 5(6):476-81. PubMed ID: 14602055
[TBL] [Abstract][Full Text] [Related]
15. Routine application of the proton-pump inhibitor pantoprazole in patients with gastric lymphoma undergoing chemotherapy.
Wöhrer S; Bartsch R; Hejna M; Drach J; Raderer M
Scand J Gastroenterol; 2005 Oct; 40(10):1222-5. PubMed ID: 16265779
[TBL] [Abstract][Full Text] [Related]
16. Inappropriate utilization of intravenous proton pump inhibitors in hospital practice--a prospective study of the extent of the problem and predictive factors.
Craig DG; Thimappa R; Anand V; Sebastian S
QJM; 2010 May; 103(5):327-35. PubMed ID: 20211846
[TBL] [Abstract][Full Text] [Related]
17. Intravenous proton-pump inhibitors versus H2-antagonists for treatment of GI bleeding.
Huggins RM; Scates AC; Latour JK
Ann Pharmacother; 2003 Mar; 37(3):433-7. PubMed ID: 12639176
[TBL] [Abstract][Full Text] [Related]
18. Dosage of intravenous pantoprazole.
Maltz C
Am J Gastroenterol; 2003 Dec; 98(12):2803-5. PubMed ID: 14687838
[No Abstract] [Full Text] [Related]
19. Early relief of upper gastrointestinal dyspeptic symptoms: a survey of empirical therapy with pantoprazole in Canadian clinical practice.
Armstrong D; Kazim F; Gervais M; Pyzyk M
Can J Gastroenterol; 2002 Jul; 16(7):439-50. PubMed ID: 12177723
[TBL] [Abstract][Full Text] [Related]
20. Double-blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer.
Beker JA; Bianchi Porro G; Bigard MA; Delle Fave G; Devis G; Gouerou H; Maier C
Eur J Gastroenterol Hepatol; 1995 May; 7(5):407-10. PubMed ID: 7614102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
